LTR Pharma (ASX:LTP) Payments to Suppliers for Goods and Services : A$-1.54 Mil (TTM As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma Payments to Suppliers for Goods and Services?

LTR Pharma's Payments to Suppliers for Goods and Services for the six months ended in Jun. 2023 was A$-1.54 Mil.

LTR Pharma's Payments to Suppliers for Goods and Services for the trailing twelve months (TTM) ended in Jun. 2023 was A$-1.54 Mil.

LTR Pharma Payments to Suppliers for Goods and Services Historical Data

The historical data trend for LTR Pharma's Payments to Suppliers for Goods and Services can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma Payments to Suppliers for Goods and Services Chart

LTR Pharma Annual Data

Trend

Jun21

Jun22

Jun23

Payments to Suppliers for Goods and Services

-0.03

-0.58

-1.54

LTR Pharma Semi-Annual Data
	Jun21	Jun22	Jun23
Payments to Suppliers for Goods and Services	-0.03	-0.58	-1.54

LTR Pharma Payments to Suppliers for Goods and Services Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Payments to Suppliers for Goods and Services represents cash paid to suppliers when purchasing goods or services by the company in the direct cash flow method.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Payments to Suppliers for Goods and Services for the trailing twelve months (TTM) ended in Jun. 2023 was A$-1.54 Mil.

LTR Pharma (ASX:LTP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Payments to Suppliers for Goods and Services

Comparable Companies

Traded in Other Exchanges

N/A

Address

9A/204 Alice Street, Brisbane, QLD, AUS, 4000

Website

https://www.ltrpharma.com

LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on market.

LTR Pharma (ASX:LTP) Headlines

No Headlines